ARCHIVES

House Medicare Reform Bill Takes A smaller Bite In Drug Reimbursement

This article is from The Cancer Letter archive.

Vol. 23 No. 24 | June 20, 1997

Download PDF Visit The Full Archive

Related Articles

FDA Approves Aranesp For Chemo-Induced Anemia

August 30, 2002

Obey Says NCI “Must Do Better,” Response Dispute GAO Conclusion

August 8, 1980

Joe Gray Moves To OHSU Knight Cancer Institute

January 21, 2011

In Brief: Sullivan Rejects Oregon Medicaid Rationing Plan; Howe To Head National Marrow Donor Program

August 7, 1992

FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate.

May 28, 2004

European Agency Recommends Transfusions Over ESAs For Cancer Patients With Longer Life Expectancy.

June 27, 2008